Myasthenia Gravis Treatment Market By Treatment Type (Cholinesterase Inhibitors, Corticosteroids, Immunosuppressants, Monoclonal Antibodies, Plasma Exchange & IVIG, Surgical Treatment), By Route of Administration (Oral, Intravenous, Subcutaneous), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), By End-User (Hospitals, Specialty Clinics, Homecare Settings, Others), Global Market Size, Segmental Analysis, Regional Overview, Company Share Analysis, Leading Company Profiles, and Market Forecast, 2025 – 2035.

Published Date: Mar 2025 | Report ID: MI2276 | 215 Pages

Report Summary Table of Contents Segmentation FAQ Request Free Sample Report

Report Coverage:

By Treatment Type

  • Cholinesterase Inhibitors
  • Corticosteroids
  • Immunosuppressants
  • Monoclonal Antibodies
  • Plasma Exchange & IVIG
  • Surgical Treatment

By Route of Administration

  • Oral
  • Intravenous
  • Subcutaneous

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

End-user

  • Hospitals
  • Specialty Clinics
  • Homecare Settings
  • Others

By Region

North America

  • U.S.
  • Canada

Europe

  • U.K.
  • France
  • Germany
  • Italy
  • Spain
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Singapore
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

List of Companies:

  • Roche
  • Bristol-Myers Squibb
  • UCB Pharma
  • Alexion Pharmaceuticals
  • Mitsubishi Tanabe Pharma
  • Sanofi
  • Grifols
  • Amgen
  • Eisai Co. Ltd.
  • Merck & Co., Inc.
  • Novartis
  • GSK (GlaxoSmithKline)
  • AbbVie
  • Teva Pharmaceutical Industries Ltd.
  • Sandoz

Maximize your value and knowledge with our 5 Reports-in-1 Bundle - over 40% off!

Our analysts are ready to help you immediately.

Request Bundle Pricing